The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics
posted on 2021-06-01, 16:00authored byAdis journals on behalf of, Luis-Emilio García-Pérez, Kristina S. Boye, Myriam Rosilio, Heike Jung, Elke Heitmann, Kirsi Norrbacka, Marco Orsini Federici, Raffaella Gentilella, Bruno Guerci, Francesco Giorgino, Ulrich Aigner, Hélène Sapin
Article full text
The above summary slide and plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).